New study at Montefiore aims to identify who can be cared for at home and who would benefit from hospital care.
NEW YORK—A new study at Montefiore Health System and Albert Einstein College of Medicine will compare the outcomes of people with coronavirus disease 2019 (COVID-19) who are monitored at home by wearable technology, to people who receive standard outpatient care. The investigators hope to determine if Remote Patient Monitoring (RPM) can be used successfully to track symptoms and flag people at risk for getting severely ill, and why.
Jonathan D. Leff, MD, FASE, vice chair, faculty and academic affairs; chief, Cardiothoracic Anesthesiology, Montefiore; and professor of anesthesiology and of cardiovascular & thoracic surgery, Einstein, is leading the study, which will include 150 people being monitored remotely by a team of medical professionals.
The team will keep a constant eye on participants’ health status in real-time, including heart rate, blood pressure, oxygen levels and temperature, all while watching for any signs of deterioration. Researchers will also enroll 150 people who get standard outpatient care, which consists of self-monitoring and follow-up phone calls from providers. The outcomes of the two groups will then be compared.
“We know that the majority of people with COVID-19 fare well recovering at home,” said Leff. “However, some people may not be comfortable managing their own symptoms or may not notice when their condition gets worse. Our study will help identify abnormal vital signs associated with declining health and hopefully prevent the development of life-threatening complications before it’s too late.”
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More